Thu., May 24, 2012 LOS ANGELES (Reuters) — Pharmaceutical companies, which were spared some of the more sweeping regulations in President Barack Obama's health care overhaul, could come under more pressure if the U.S. Supreme Court strikes down part or all of the 2010 law.

Register or login for access to this item and much more

All Employee Benefit Adviser content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access